277 related articles for article (PubMed ID: 24772965)
1. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
Kumudini N; Umai A; Devi YP; Naushad SM; Mridula R; Borgohain R; Kutala VK
Indian J Biochem Biophys; 2013 Oct; 50(5):436-41. PubMed ID: 24772965
[TBL] [Abstract][Full Text] [Related]
2. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
[TBL] [Abstract][Full Text] [Related]
3. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.
Torkaman-Boutorabi A; Ali Shahidi G; Choopani S; Reza Zarrindast M
Folia Neuropathol; 2012; 50(4):382-9. PubMed ID: 23319194
[TBL] [Abstract][Full Text] [Related]
4. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.
Białecka M; Droździk M; Honczarenko K; Gawrońska-Szklarz B; Stankiewicz J; Dabrowska E; Kubisiak M; Kłodowska-Duda G; Opala G
Eur Neurol; 2005; 53(2):68-73. PubMed ID: 15753616
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
BMC Neurol; 2011 Jul; 11():89. PubMed ID: 21781348
[TBL] [Abstract][Full Text] [Related]
6. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
7. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
Vallelunga A; Flaibani R; Formento-Dojot P; Biundo R; Facchini S; Antonini A
Parkinsonism Relat Disord; 2012 May; 18(4):397-9. PubMed ID: 22113132
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
Zhang Y; Piao X; Wu J; Li Y; Liang Q
Int J Neurosci; 2016; 126(5):400-7. PubMed ID: 26000819
[TBL] [Abstract][Full Text] [Related]
9. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese.
Wu RM; Cheng CW; Chen KH; Lu SL; Shan DE; Ho YF; Chern HD
Neurology; 2001 Feb; 56(3):375-82. PubMed ID: 11171904
[TBL] [Abstract][Full Text] [Related]
10. Variability and validity of polymorphism association studies in Parkinson's disease.
Tan EK; Khajavi M; Thornby JI; Nagamitsu S; Jankovic J; Ashizawa T
Neurology; 2000 Aug; 55(4):533-8. PubMed ID: 10953187
[TBL] [Abstract][Full Text] [Related]
11. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes.
Schellekens AF; Franke B; Ellenbroek B; Cools A; de Jong CA; Buitelaar JK; Verkes RJ
Arch Gen Psychiatry; 2012 Apr; 69(4):339-48. PubMed ID: 22474103
[TBL] [Abstract][Full Text] [Related]
12. The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson's disease.
Torkaman-Boutorabi A; Shahidi GA; Choopani S; Rezvani M; Pourkosary K; Golkar M; Zarrindast MR
Acta Neurobiol Exp (Wars); 2012; 72(3):272-82. PubMed ID: 23093014
[TBL] [Abstract][Full Text] [Related]
13. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
Bialecka M; Klodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Safranow K; Droździk M
Parkinsonism Relat Disord; 2007 May; 13(4):224-9. PubMed ID: 17270484
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
[TBL] [Abstract][Full Text] [Related]
16. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
[TBL] [Abstract][Full Text] [Related]
17. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.
Gupta M; Chauhan C; Bhatnagar P; Gupta S; Grover S; Singh PK; Purushottam M; Mukherjee O; Jain S; Brahmachari SK; Kukreti R
Pharmacogenomics; 2009 Feb; 10(2):277-91. PubMed ID: 19207030
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele.
Planté-Bordeneuve V; Taussig D; Thomas F; Said G; Wood NW; Marsden CD; Harding AE
Neurology; 1997 Jun; 48(6):1589-93. PubMed ID: 9191771
[TBL] [Abstract][Full Text] [Related]
20. Impact of COMT Val 108/158 Met and DRD2 Taq1B gene polymorphisms on vulnerability to cigarette smoking of Thai males.
Suriyaprom K; Tungtrongchitr R; Harnroongroj T
J Mol Neurosci; 2013 Mar; 49(3):544-9. PubMed ID: 22740151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
